Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Canopy Growth CorporationTSX: WEED.TO

Cost of Revenue · Q4 FY2025 · quarter ended Mar 2026

Cost of revenue grows, but more slowly than its trailing trend

Q4 FY2025 cost of revenue of CA$62.98M rose 15.6% year over year, behind the +25.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 8.9% from the prior quarter. Over 3 fiscal years it compounded at -20.7% a year.

Context

  • Cost of revenue amounted to 75.5% of revenue in FY2025, up 5.1 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +15.6% toward the trailing-twelve-month pace of +25.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$62.98M+8.9% QoQ
Last fiscal yearMar 2026
CA$214.93M+13.4% YoY
LTMMar 2026
CA$237.39M+25.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.6%——
1 year+13.4%——
3-year CAGR-20.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

CAD · from the income statement

Latest · FY2025
214.93M CAD
Year-over-year change
+13.4%
4-year CAGR
-24.3%

Cost of Revenue vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +25.3% is the 6th highest of 8, against a peer median of +37.3%.
  • Cost of revenue amounts to 76.4% of revenue for WEED.TO, versus a peer median of 52.5%.
WEED.TO Competitors
Cost of Revenue for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$282.6M CAD+116.3%—103.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$237.39M CAD+25.3%-20.7%76.4%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$218.14M CAD+40.1%+0.7%68.5%
TSND.TOTerrAscend Corp.LTM Mar 2026$128.47M USD-10.2%-13.4%49.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$83.17M CAD+37.3%-6.0%52.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$12.97M USD+17.0%+63.9%25.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$4.95M CAD+344.3%+123.1%179.2%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$3.99M USD+32.6%+252.4%7.8%
Peer median (excluding WEED.TO) —+37.3%+32.3%52.5%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M284.6M
Cost of Revenue653.93M431.64M216.26M189.48M214.93M
Gross Profit(143.6M)(98.38M)80.88M79.51M69.67M
Gross Margin-30.2%-29.5%27.2%29.6%24.5%
Research & Development32.26M21.72M4.61M2.74M0
Selling, General & Admin361.1M297.98M175.98M121.71M122.93M
Operating Expenses445.08M297.4M309.6M196.65M142.78M
Depreciation & Amortization110.94M80.03M53.18M43.12M36.47M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)(188.22M)
EBITDA Margin-11.1%-864.2%-105.3%-178.2%-66.1%
Operating Income(588.69M)(395.78M)(228.71M)(117.14M)(73.11M)
Operating Margin-123.8%-118.8%-77.0%-43.5%-25.7%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses370.63M(2.69B)(242.64M)(479.85M)(189.78M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-92.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(262.91M)
Net Margin-65.2%-983.7%-221.2%-222.4%-92.4%
EPS (Basic)(0.81)(12.18)(8.79)(5.56)(0.76)
EPS (Diluted)(0.81)(12.18)(8.79)(5.56)(0.76)
Weighted Avg Shares396.1M271.61M74.79M107.55M345.53M
Weighted Avg Shares (Diluted)396.36M271.61M74.79M107.55M345.53M

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.